The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism [INNATE IMMUNITY AND INFLAMMATION]

Fensterheim, B. A., Young, J. D., Luan, L., Kleinbard, R. R., Stothers, C. L., Patil, N. K., McAtee-Pereira, A. G., Guo, Y., Trenary, I., Hernandez, A., Fults, J. B., Williams, D. L., Sherwood, E. R., Bohannon, J. K.
The American Association of Immunologists (AAI)
Published 2018